Thyroid cancers are usually detected as nodules found during physical examination or as incidental findings on imaging. If a malignancy is confirmed or suspected based on cytology, or if cytology is indeterminate, pre- and postoperative histologic examination and testing for molecular markers can be used to confirm the diagnosis, differentiate between thyroid cancer subtypes, inform prognosis, and guide treatment. If a familial syndrome is suspected, germline testing may be warranted.

Refer to ARUP Laboratories’ test offerings below.